Status:
COMPLETED
Role of Synchronized Lifestyle Modification Program on Diabetic Neuropathy Taking Oral Hypoglycemics
Lead Sponsor:
Riphah International University
Conditions:
Diabetic Neuropathies
Eligibility:
All Genders
40-75 years
Phase:
NA
Brief Summary
The aim of this study is to determine the combined effect of SLP along with Physiotherapy in improving Type 2 DPN patients taking OHAs and GLP-1 analogues.
Detailed Description
Diabetes mellitus (DM) is a chronic metabolic disease defined by persistently increased blood glucose levels with fasting blood glucose ≥ 126 mg/dl, random plasma glucose ≥ 200mg/dl and HbA1c ≥ 6.5%. ...
Eligibility Criteria
Inclusion
- Gender includes both male and female
- Patients between age group 40-75 years
- Clinically diagnosed patients of Type 2 diabetes on OHAs and GLP-1 analogues
- Diabetic patients with symptomatic peripheral neuropathy (Severity of DPN is associated with a physical examination score \> 2.5 by using Michigan Neuropathy Screening Instrument (MNSI) with grades mild, moderate and severe)
Exclusion
- Type 1 diabetic patients
- Age \< 40 years and \> 75 years
- Patients with any other co-morbidities (Heart, liver and kidney diseases)
- Patients with neuropathies due to any other disease
- Orthopaedic and surgical procedure of lower limbs
- Patients with foot ulcers
- Peripheral vascular diseases
- Patients receiving any structured supervised physiotherapy
- Pregnant females
Key Trial Info
Start Date :
February 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2022
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT04813146
Start Date
February 5 2021
End Date
January 30 2022
Last Update
November 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pakistan Railway Hospital
Islamabad, Federal, Pakistan, 44000